BERLIN, Sept. 1, 2016 /PRNewswire/ -- At this year's
Internationale Funkausstellung (IFA), taking place in Berlin, Germany from September 2-7, Royal Philips (NYSE: PHG, AEX:
PHIA) is presenting innovations that empower people to live
healthier lives across the health continuum, from prevention, to
diagnosis, to treatment. During this year's show, Philips will
highlight its vision for transforming the future of sleep. With
more patients seeking medical care for sleep disorders1,
the world is waking up to the challenge of healthy sleep, its
impact on overall health and the need for a good night's rest.
During IFA, Philips will present innovations that help people
get the rest they deserve, including the Dream Family solution
designed to improve the sleep therapy experience for people with
obstructive sleep apnea (OSA). More than 100 million people
worldwide2 are estimated to have OSA, a serious
condition that is treated with positive airway pressure (PAP)
therapy. The Dream Family, comprised of the DreamWear mask,
DreamStation PAP device and DreamMapper patient engagement app, is
designed to engage sleep apnea patients with one of the most
comfortable and effective therapies available. With the most
comprehensive suite of connectivity options among all PAP therapy
systems, Dream Family works as a connected solution to keep
patients engaged in their therapy and linked to their care
teams.
The components of the Dream Family were inspired by feedback
from more than 900 patients, as well as insights from clinicians
who treat sleep apnea. This input, combined with Philips' more than
four decades of experience developing revolutionary patient-centric
solutions, led to the award-winning design of the Dream Family.
Since their launch in October 2015,
DreamWear and DreamStation have been honored for excellence in
design, including recent iF Design, Red Dot, Good Design Australia
and Core77 accolades.
"Sleep therapy can be challenging, and our goal is to help
people across the globe get a better night's rest – whether they
live with a chronic sleep condition or are struggling to achieve
eight hours a night," said John
Frank, CEO, Sleep and Respiratory Care, Philips. "Next to
nutrition and exercise, sleep is the third pillar of health and now
we are looking to the future for all people who need help with
improving their sleep quality. We intend to make good sleep
possible for everyone."
In addition to the Dream Family, Philips will be showcasing two
light therapy solutions designed to improve the experience of
getting out of bed. These include:
- EnergyUp Energy Lights: Philips' EnergyUp lights help
combat energy dips caused by jet lag, long hours inside an office
or general fatigue. The EnergyUp Natural White light mimics the
natural energizing power of daylight, and is clinically proven to
increase energy levels and mood to help users stay
sharp3. With its highly portable design, the EnergyUp
Intense Blue light is easy for people to use when traveling or at
the office, the environments where people are most likely to
experience fatigue.
- Wake-up Light: Inspired by nature's sunrise, the Philips
Wake-up Light creates a gentle, refreshing wake-up experience to
wake the user up gradually. It is clinically proven to provide a
more energetic wake-up in the morning4, and provides a
relaxed, easy wake-up and reduces sleepiness after waking up.
Available in a variety of options and price points, the technology
allows users to simulate the sunrise and choose the preferred sound
for their wake-up.
Philips at IFA
The Philips press conference takes
place on September 1 at 12:15pm in Hall 22, Messe Berlin. The live stream
of the event can be seen at www.ifa.philips.com. Pieter Nota, CEO
Personal Health businesses and Chief Marketing Officer at Philips,
will be joined on stage by Chris
Worp, Head of Business Group Home from Philips Lighting, and
Kostas Vouzas, Senior Director Business EMEA at TP Vision.
For further information on the latest Philips innovations at IFA
2016 please visit www.ifa.philips.com, follow Philips at IFA on
Twitter @PhilipsLiveFrom, or visit our additional social media
channels on YouTube and LinkedIn.
For further information, please contact:
Alicia Cafardi
Philips
alicia.cafardi@philips.com
412-523-9616
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better outcomes
across the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to deliver
integrated solutions. The company is a leader in diagnostic
imaging, image-guided therapy, patient monitoring and health
informatics, as well as in consumer health and home care.
Headquartered in the Netherlands,
Philips' health technology portfolio generated 2015 sales of
EUR 16.8 billion and employs
approximately 69,000 employees with sales and services in more than
100 countries. News about Philips can be found at
www.philips.com/newscenter.
1 Ford ES, Wheaton AG, Cunningham TJ, Giles WH,
Chapman DP, Croft JB. Trends in outpatient visits for insomnia,
sleep apnea, and prescriptions for sleep medications among US
adults: findings from the National Ambulatory Medical Care Survey
1999-2010.
2 http://www.stopbang.ca/osa/prevalence.php
3 Duijzer & Meesters THE EFFECTS OF LOW
INTENSITY MONOCHROMATIC BLUE LIGHT TREATMENT COMPARED TO STANDARD
LIGHT TREATMENT IN SUB- SYNDROMAL SAD; SLTBR Abstracts 2011,
p.33
4 Giménez, M.C., Hessels, M., van de Werken, M., de Vries, B., Beersma,
D.G.M., & Gordijn, M. C. M. (2010). Effects of artificial dawn
on subjective ratings of sleep inertia and dim light melatonin
onset. Chronobiology International, 27(6), 1219–1241.
doi:10.3109/07420528.2010.496912
Logo -
http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-showcases-commitment-to-helping-the-world-sleep-better-with-innovative-sleep-disordered-breathing-solutions-and-light-therapy-innovations-at-ifa-300321043.html
SOURCE Royal Philips